MUSE alprostadil data

VVUS (Menlo Park, Calif.) reported summary results from the home treatment portion of its two Phase III studies of MUSE alprostadil in 996 men with erectile dysfunction of organic origin.

Of the total active doses administered, 50.4 percent resulted in patients having successful intercourse compared to 10.4 percent for placebo (p<0.001). All dosages resulted in statistically significant results. ...